Occudo Quantitative Strategies’s Avadel Pharmaceuticals AVDL Stock Holding History

Occudo Quantitative Strategies’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-53,730	Closed	-$1.16M	–	744
2025 Q4	$1.16M	Buy	+53,730	New	+$1.04M	0.08%	290
2025 Q3	–	Sell	-14,046	Closed	-$124K	–	670
2025 Q2	$124K	Buy	+14,046	New	+$123K	0.01%	563

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Occudo Quantitative Strategies's AVDL Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 53,730 shares — an estimated $1.16M sold.

Occudo Quantitative Strategies first reported a position in AVDL in Q2 2025 and held it in 2 quarters. The position peaked at $1.16M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Occudo Quantitative Strategies reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Occudo Quantitative Strategies sold 53,730 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.16M.
Occudo Quantitative Strategies first reported a position in Avadel Pharmaceuticals in Q2 2025 and held it in 2 quarters.
Occudo Quantitative Strategies's Avadel Pharmaceuticals position peaked at $1.16M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.